Bye-Bye Bifocals: The Rise of Presbyopia Eye Drops in Ireland
- Michéal O'Rourke
- Sep 30
- 4 min read
Which would you prefer — constantly taking glasses on and off all day, or the simplicity of a single daily eye drop?
For many of us, reading glasses are a love–hate relationship: indispensable when you can find them, endlessly frustrating when you can’t. The promise of freeing yourself from that cycle is exactly why presbyopia-correcting eye drops are generating so much excitement across Ireland.

The “Lost Glasses” Hack
If you’ve just had your specs and now can’t find them — check your head first! And if they’re not there, don’t worry: they’re always exactly where you left them (even if your memory says otherwise).
Presbyopia: Why It Hits Us in Our Prime
Ever notice that once you and your friends hit your 40s, everyone suddenly starts reaching for reading glasses? That’s presbyopia — a completely normal, age-related change where the eye’s natural lens stiffens and loses flexibility for near vision.
Frustratingly, it doesn’t wait for old age. It arrives in the middle of life — when we’re busiest with work, family, and everything in between. That’s why many of us end up with pairs of reading glasses scattered across the car, the house, and the office — and still can’t find them when needed.
Why Do We Get Presbyopia?
Presbyopia isn’t a flaw — it’s simply a side effect of ageing. As the eye’s lens hardens over time, it struggles to refocus between near and far objects.
Evolution didn’t “fix” it because presbyopia typically appears after our prime reproductive years. Distance vision — crucial for survival — remained sharper for longer, while close-up focus faded later in life.
The Science Behind Presbyopia Eye Drops
How VIZZ Works
Active Ingredient: Aceclidine (1.75%)
Mechanism: Causes gentle pupil constriction to create a “pinhole effect,” improving near vision without reducing distance focus.
Duration: Up to 10 hours of sharper near vision.
Who It’s For: Adults with presbyopia seeking a reading glasses alternative in Ireland.
Why It Stands Out: Once-daily dosing, preservative-free, and completely non-invasive.
Why This Could Be a Reading-Vision Revolution
Benefit | Why It Matters |
No more glass hunts | Freedom from constantly swapping or losing specs. |
Clarity on demand | Apply drops when you need to read, work, or scroll. |
No surgery or lenses | Just a drop — yet real, functional near vision. |
Temporary and reversible | Safe, flexible, and fades naturally when not needed. |
Myth-Buster: What These Drops Can — and Can’t — Do
Myth | Truth |
These drops cure presbyopia forever | ❌ No — they provide temporary improvement, not a permanent fix. |
They’re “liquid glasses” | ❌ Not exactly — they work biologically, not optically. |
You’ll never need glasses again | ⚠️ You may still need correction for some tasks. |
Long-term safety is fully known | ⚠️ FDA-approved, but ongoing research continues to track long-term effects. |
What to Know Before Trying VIZZ
Expect flexible improvement — not a cure — with results lasting up to 10 hours.
Follow dosage carefully: one drop per eye daily (as instructed).
Mild side effects may include irritation, light sensitivity, or headaches.
Always consult your eye doctor first, especially if you have high myopia or a history of retinal issues.
Emerging Alternatives: Not Just VIZZ Anymore
If VIZZ excites you, other promising presbyopia eye drops are also on the way to Ireland:
Qlosi (pilocarpine 0.4%)
FDA-approved in late 2023; U.S. launch in 2025.
Uses the “pinhole effect” with a gentler formula lasting 6–8 hours.
Preservative-free, single-use vials via EyeQ™ technology.
Vuity (pilocarpine 1.25%)
First FDA-approved drop (2021).
Provides 4–6 hours of improved near vision per dose.
Widely used and well-studied.
Coming Soon
Brimochol PF: Dual-action, preservative-free; expected 2026.
MR-141 / Nyxol: In late-stage clinical trials with strong early results.
Comparing the New Presbyopia Eye Drops
Drop | Main Ingredient | Duration | Dosing | Key Features | Availability |
VIZZ | Aceclidine 1.75% | Up to 10 hrs | Once daily (2 drops per eye, 2 mins apart) | Longest-lasting, preservative-free | FDA-approved (US 2025), EU/Ireland expected 2026 |
Qlosi | Pilocarpine 0.4% | 6–8 hrs | Once or twice daily | Gentle formulation, EyeQ™ single-use vials | US 2025; EU TBD |
Vuity | Pilocarpine 1.25% | 4–6 hrs | Once or twice daily | First-to-market, well studied | US 2021; EU rollout variable |
Quick Take
VIZZ: Longest-lasting and most convenient — coming soon.
Qlosi: Gentler pilocarpine alternative — US launch 2025.
Vuity: First and most proven — shorter duration.
When Will VIZZ Be Available in Ireland?
US: Launch expected in late 2025 following FDA approval.
Ireland/EU: Awaiting CE marking, with likely rollout between early and mid-2026 depending on regulatory timelines.
Final Thoughts
Presbyopia is a natural part of ageing — but searching endlessly for your reading glasses doesn’t have to be.
Whether it’s the upcoming VIZZ eye drop, the new Qlosi, or the established Vuity, these FDA-approved near vision correction options are transforming how we manage close-up sight.
No more fumbling for specs — just clearer vision on demand, with a simple drop.
Ready to Learn More?
If you’re curious whether presbyopia eye drops in Ireland are right for you, contact your local optometrist or book a consultation to discuss your options.
.png)




Comments